Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes

July 16, 2026

Recorded session:

https://ihs-gov.zoomgov.com/

Passcode: 2by0pMC.

Description:

This session will review current best practices for the identification, evaluation, and management of metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with type 2 diabetes, with a focus on early detection, risk stratification, and coordinated patient care.

Presenter:

Carol Greenlee, MD, MACP, Physician (Endocrinology)

Downloads:

PowerPoint Presentation (PDF)

Continuing Education (CE) Flyer (PDF)